Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-205-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20110216.11.3-205-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
".
Given the ever-growing risks to patients from counterfeit medicines, I think that interim measures to strengthen patient safety need to be introduced urgently. These measures must stipulate that manufacturing authorisation holders who remove or cover up overt safety features applied on a voluntary basis by manufacturers be held strictly liable in the event of counterfeits entering the supply chain as a result of their actions."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples